Flumatinib Versus Nilotinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
NCT04739826
·
clinicaltrials.gov ↗
UNKNOWN
Status
491
Enrollment
OTHER
Sponsor class
Conditions
CML, Chronic Phase; TKI
Interventions
DRUG:
Flumatinib Mesylate
DRUG:
Nilotinib Pill
Sponsor
The First Affiliated Hospital of Soochow University